ESCITALOPRAM

Escitalopram Adverse Events Reported to the FDA Over Time

How are Escitalopram adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Escitalopram, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Escitalopram is flagged as the suspect drug causing the adverse event.

Most Common Escitalopram Adverse Events Reported to the FDA

What are the most common Escitalopram adverse events reported to the FDA?

Completed Suicide	559 (1.83%)
Drug Interaction	473 (1.55%)
Anxiety	373 (1.22%)
Suicide Attempt	321 (1.05%)
Fall	319 (1.04%)
Hyponatraemia	311 (1.02%)
Dizziness	295 (.97%)
Nausea	294 (.96%)
Depression	286 (.94%)
Suicidal Ideation	279 (.91%)
Overdose	269 (.88%)
	Show More
Confusional State	265 (.87%)
Convulsion	263 (.86%)
Tremor	262 (.86%)
Somnolence	261 (.85%)
Loss Of Consciousness	253 (.83%)
Fatigue	238 (.78%)
Drug Exposure During Pregnancy	230 (.75%)
Condition Aggravated	226 (.74%)
Agitation	219 (.72%)
Malaise	217 (.71%)
Vomiting	210 (.69%)
Serotonin Syndrome	209 (.68%)
Intentional Overdose	202 (.66%)
Insomnia	199 (.65%)
Headache	188 (.62%)
Cardiac Arrest	185 (.61%)
Asthenia	176 (.58%)
Multiple Drug Overdose Intentional	175 (.57%)
Diarrhoea	158 (.52%)
Restlessness	144 (.47%)
Pregnancy	143 (.47%)
Aggression	138 (.45%)
Feeling Abnormal	135 (.44%)
Drug Ineffective	134 (.44%)
Dyspnoea	134 (.44%)
Maternal Drugs Affecting Foetus	134 (.44%)
Caesarean Section	133 (.44%)
Respiratory Arrest	127 (.42%)
Hypotension	126 (.41%)
Grand Mal Convulsion	121 (.4%)
Hyperhidrosis	119 (.39%)
Decreased Appetite	115 (.38%)
Dyskinesia	115 (.38%)
Tachycardia	115 (.38%)
Weight Increased	115 (.38%)
Paraesthesia	114 (.37%)
Pyrexia	113 (.37%)
Drug Toxicity	112 (.37%)
Coma	108 (.35%)
Disorientation	108 (.35%)
Rhabdomyolysis	108 (.35%)
Drug Withdrawal Syndrome	107 (.35%)
Multiple Drug Overdose	101 (.33%)
Hypertension	97 (.32%)
Syncope	97 (.32%)
Weight Decreased	96 (.31%)
Abdominal Pain	94 (.31%)
Irritability	92 (.3%)
Electrocardiogram Qt Prolonged	91 (.3%)
Disturbance In Attention	89 (.29%)
Off Label Use	88 (.29%)
Cytolytic Hepatitis	87 (.28%)
General Physical Health Deteriorati...	87 (.28%)
Speech Disorder	86 (.28%)
Aspartate Aminotransferase Increase...	85 (.28%)
Urinary Retention	83 (.27%)
Epilepsy	81 (.27%)
Renal Failure	80 (.26%)
Alanine Aminotransferase Increased	79 (.26%)
Blood Creatine Phosphokinase Increa...	78 (.26%)
Death	77 (.25%)
Dysarthria	77 (.25%)
Delirium	76 (.25%)
Panic Attack	74 (.24%)
Renal Failure Acute	74 (.24%)
Sleep Disorder	74 (.24%)
Balance Disorder	73 (.24%)
Gamma-glutamyltransferase Increased	73 (.24%)
Gait Disturbance	72 (.24%)
Amnesia	71 (.23%)
Urinary Tract Infection	71 (.23%)
International Normalised Ratio Incr...	70 (.23%)
Blood Pressure Increased	69 (.23%)
Haemoglobin Decreased	68 (.22%)
Hallucination	68 (.22%)
Abnormal Behaviour	66 (.22%)
Bradycardia	66 (.22%)
Palpitations	66 (.22%)
Anaemia	65 (.21%)
Crying	65 (.21%)
Neuroleptic Malignant Syndrome	65 (.21%)
Poisoning	65 (.21%)
Product Substitution Issue	65 (.21%)
Depressed Level Of Consciousness	64 (.21%)
Abdominal Pain Upper	62 (.2%)
Blood Sodium Decreased	61 (.2%)
Hypokalaemia	61 (.2%)
Oedema Peripheral	61 (.2%)
Vertigo	61 (.2%)
Withdrawal Syndrome	61 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Escitalopram, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Escitalopram is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Escitalopram

What are the most common Escitalopram adverse events reported to the FDA?

Neurological	2210 (7.24%)
Suicidal And Self-injurious Behavio...	1296 (4.24%)
Cardiac Arrhythmias	951 (3.11%)
Anxiety Disorders	895 (2.93%)
Medication Errors	853 (2.79%)
Therapeutic And Nontherapeutic Effe...	853 (2.79%)
Gastrointestinal Signs	823 (2.69%)
Movement Disorders	772 (2.53%)
Respiratory	698 (2.29%)
Chemical Injury And Poisoning	628 (2.06%)
Seizures	577 (1.89%)
	Show More
Injuries	550 (1.8%)
Electrolyte And Fluid Balance Condi...	532 (1.74%)
Depressed Mood Disorders	522 (1.71%)
Hepatic And Hepatobiliary	499 (1.63%)
Hematology Investigations	495 (1.62%)
Sleep Disorders	465 (1.52%)
Epidermal And Dermal Conditions	453 (1.48%)
Deliria	451 (1.48%)
Muscle	439 (1.44%)
Cardiac And Vascular Investigations	380 (1.24%)
Neuromuscular	378 (1.24%)
Infections - Pathogen Unspecified	354 (1.16%)
Hepatobiliary	347 (1.14%)
Disturbances In Thinking	316 (1.03%)
Personality Disorders	315 (1.03%)
Mental Impairment	312 (1.02%)
Physical Examination Topics	290 (.95%)
Urinary Tract Signs	262 (.86%)
Appetite And General Nutritional	261 (.85%)
Gastrointestinal Motility And Defec...	249 (.82%)
Mood Disorders	248 (.81%)
Vision	245 (.8%)
Water, Electrolyte And Mineral	240 (.79%)
Central Nervous System Vascular	232 (.76%)
Decreased And Nonspecific Blood Pre...	231 (.76%)
Psychiatric	224 (.73%)
Renal Disorders	214 (.7%)
Gastrointestinal Hemorrhages	208 (.68%)
Headaches	200 (.65%)
Enzyme	185 (.61%)
Lifestyle Issues	185 (.61%)
Changes In Physical Activity	178 (.58%)
Skin Appendage Conditions	175 (.57%)
Obstetric And Gynecological Therape...	163 (.53%)
Musculoskeletal And Connective Tiss...	161 (.53%)
Metabolic, Nutritional And Blood Ga...	160 (.52%)
Cardiac Disorder Signs	156 (.51%)
Pregnancy, Labour, Delivery And Pos...	155 (.51%)
Renal And Urinary Tract Investigati...	152 (.5%)
Body Temperature Conditions	146 (.48%)
White Blood Cell	133 (.44%)
Ocular Neuromuscular	131 (.43%)
Anemias Nonhemolytic And Marrow Dep...	129 (.42%)
Therapeutic Procedures And Supporti...	123 (.4%)
Fatal Outcomes	113 (.37%)
Vascular Hypertensive	113 (.37%)
Coronary Artery	109 (.36%)
Manic And Bipolar Mood Disorders	108 (.35%)
Inner Ear And Viiith Cranial Nerve	105 (.34%)
Bone And Joint Injuries	104 (.34%)
Lower Respiratory Tract Disorders	103 (.34%)
Psychiatric And Behavioural Symptom...	103 (.34%)
Vascular	101 (.33%)
Protein And Chemistry Analyses	99 (.32%)
Endocrine Investigations	98 (.32%)
Upper Respiratory Tract Disorders	96 (.31%)
Breast	95 (.31%)
Lipid Analyses	92 (.3%)
Platelet	84 (.28%)
Toxicology And Therapeutic Drug Mon...	84 (.28%)
Abortions And Stillbirth	83 (.27%)
Joint	81 (.27%)
Neonatal And Perinatal Conditions	78 (.26%)
Glucose Metabolism Disorders	77 (.25%)
Acid-base	76 (.25%)
Allergic Conditions	76 (.25%)
Neurological, Special Senses And Ps...	75 (.25%)
Schizophrenia And Other Psychotic	75 (.25%)
Product Quality Issues	72 (.24%)
Sexual Function And Fertility	72 (.24%)
Cardiac And Vascular Disorders Cong...	68 (.22%)
Arteriosclerosis, Stenosis, Vascula...	66 (.22%)
Myocardial	66 (.22%)
Sexual Dysfunctions, Disturbances A...	66 (.22%)
Heart Failures	65 (.21%)
Menstrual Cycle And Uterine Bleedin...	65 (.21%)
Salivary Gland Conditions	65 (.21%)
Vascular Hemorrhagic	63 (.21%)
Skin Vascular Abnormalities	62 (.2%)
Hypothalamus And Pituitary Gland	60 (.2%)
Bacterial Infectious	58 (.19%)
Oral Soft Tissue Conditions	58 (.19%)
Gastrointestinal Inflammatory Condi...	55 (.18%)
Angiedema And Urticaria	54 (.18%)
Communication Disorders	54 (.18%)
Eye	54 (.18%)
Pulmonary Vascular	53 (.17%)
Gastrointestinal Ulceration And Per...	51 (.17%)
Maternal Complications Of Pregnancy	50 (.16%)
Sleep Disturbances	50 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Escitalopram, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Escitalopram is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.